Ca2+ channel alpha2-delta ligands for the treatment of neuropathic pain

J Med Chem. 2007 May 31;50(11):2569-75. doi: 10.1021/jm060650z. Epub 2007 May 10.
No abstract available

Publication types

  • Review

MeSH terms

  • Amines / chemistry
  • Amines / pharmacology
  • Amines / therapeutic use
  • Analgesics / chemistry
  • Analgesics / pharmacology*
  • Analgesics / therapeutic use
  • Animals
  • Anticonvulsants / chemistry
  • Anticonvulsants / pharmacology
  • Anticonvulsants / therapeutic use
  • Calcium Channels / genetics
  • Calcium Channels / metabolism
  • Calcium Channels / physiology*
  • Carboxylic Acids / chemistry
  • Carboxylic Acids / pharmacology
  • Carboxylic Acids / therapeutic use
  • Cyclohexanecarboxylic Acids / chemistry
  • Cyclohexanecarboxylic Acids / pharmacology
  • Cyclohexanecarboxylic Acids / therapeutic use
  • Gabapentin
  • Humans
  • Ligands
  • Mice
  • Mice, Mutant Strains
  • Pain / drug therapy*
  • Pain / metabolism
  • Peripheral Nervous System Diseases / drug therapy*
  • Peripheral Nervous System Diseases / metabolism
  • Peripheral Nervous System Diseases / physiopathology
  • Pregabalin
  • Prodrugs / chemistry
  • Prodrugs / pharmacology
  • Prodrugs / therapeutic use
  • gamma-Aminobutyric Acid / analogs & derivatives
  • gamma-Aminobutyric Acid / chemistry
  • gamma-Aminobutyric Acid / pharmacology
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Amines
  • Analgesics
  • Anticonvulsants
  • Calcium Channels
  • Carboxylic Acids
  • Cyclohexanecarboxylic Acids
  • Ligands
  • Prodrugs
  • voltage gated calcium channel subunit Ca alpha2delta-1, human
  • Pregabalin
  • gamma-Aminobutyric Acid
  • Gabapentin